Stock performs better than expected for Redwood City’s Genomic Health
Genomic Health, based in Redwood City, offers diagnostic tests for breast and colon cancer. Stocks were up last quarter due to due high demand for its Oncotype DX diagnostic test.
NASDAQ: GHDX
CEO’s dedication is behind Genomic Health’s cancer tests
From personally raising funds for new cancer tests, to knowing almost all her employees names and buying neon bikes for them to ride around campus, Kim Popovits leads Genomic Health.
Redwood City company at the forefront of personalized medicine
Silicon Valley is one of the hotspots in personalized medicine research and technology. Redwood City’s Genomic Health is poised to lead the way.
Redwood City’s Genomic Health announces new subsidary, but earnings fall shy of predictions
Genomic Health, Inc. reported fourth quarter and yearlong earnings last week, which came slightly short of analysts’ expectations, but executives made a surprise announcement: a new subsidiary to focus on DNA sequencing.